When was Avance Clinical founded?

Avance Clinical was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Where is Avance Clinical located?

Avance Clinical is headquartered in Thebarton, Australia.

Who is the current CEO of Avance Clinical?

Yvonne Lungershausen of Avance Clinical.

How many employees does Avance Clinical have?

As of Jun 30, 2026, the latest employee count at Avance Clinical is 431.

Is Avance Clinical a funded company?

Avance Clinical is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on Nov 09, 2021.

When was the latest funding round of Avance Clinical?

Avance Clinical's latest funding was a $***** PE round on Nov 09, 2021, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. Globally, the Biopharma Outsourcing sector has seen $1.1B in funding in 2026 to date.

Where does Avance Clinical rank among its competitors?

Avance Clinical ranks 6th amongst 100 active competitors, of which 7 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was MindBio Therapeutics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of Avance Clinical?

Avance Clinical's top competitors include Celerion, HMR London and Altasciences. Among them, MindBio Therapeutics secured the most recent funding round in April, 2026.

Avance Clinical - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.avancecro.com/
Email ID: *****@avancecro.com
Phone Number: +61 **********

Key Metrics

Founded Year

2018

Location

Thebarton, Australia

Stage

Late Stage

Latest Funding Round

PE, Nov 09, 2021, $*****

Investors

Riverside & 1 more

Ranked

6^th among 100 active competitors

Employee Count

431 as on Jun 30, 2026

Investment & Acquisitions

LumaBridge & 1 more

Similar Companies

Celerion & 119 more

View Avance Clinical's full profile

Avance Clinical has raised funding over 1 round. Its latest funding round was a PE round on Nov 09, 2021 for $*****. 1 investor participated in its latest round. Avance Clinical has 2 institutional investors.

Here is the list of recent funding rounds of Avance Clinical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 09, 2021	4237478	PE	8847442	3180774	4739292	4240371

Access funding benchmarks and valuations. Sign up today!

View details of Avance Clinical's funding rounds and investors

Avance Clinical's employee count trend

Avance Clinical has 431 employees as of Jun 26. Here is Avance Clinical's employee count trend over the years:

Employee count trend for Avance Clinical

Uncover Avance Clinical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Avance Clinical include Celerion, HMR London and Altasciences. Here is the list of Top 10 competitors of Avance Clinical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Celerion 2010, Lincoln (United States), Acquired	Translational medicine experts accelerating drug development for global patient impact	-	Bain Capital Ventures, H.I.G. Private Equity ... & 7 others	51/100
2nd	HMR London 1993, London (United Kingdom), Acquired	Provider of early phase clinical research services for drug development	-	Europa, EIC Fund	51/100
3rd	Altasciences 2015, Laval (Canada), Acquired	Early phase CRO	-	Apollo Investment Corporation, Signet Healthcare Partners ... & 1 others	50/100
4th	BioPharma Services 2006, Toronto (Canada), Acquired	Provider of early stage clinical trial services	-	-	48/100
5th	MindBio Therapeutics 2021, Melbourne (Australia), Public	Provider of phase I & II clinical trial services for mental health diseases	-	Blackhawk Growth Corp, Hardenbrook Group	44/100
6th	Avance Clinical 2018, Thebarton (Australia), Late Stage	Provider of clinical development services	-	Riverside, Genesis Capital	43/100
7th	Aditum Bio 2019, Oakland (United States), Unfunded	CRO focused on clinical trial on phase II studies	-	-	42/100
8th	iCardiac Technologies 2006, Rochester (United States), Acquired	Company offering core laboratory services mainly for cardiac safety testing and respiratory diseases	$4M	Stonehenge Growth Equity Partners, Norwest ... & 4 others	41/100
9th	Unravel Biosciences 2020, Boston (United States), Seed	CRO offering early stage clinical development of drugs	$500K	BoxOne Ventures, Beresford Ventures	40/100
10th	Ventura Biomed 2021, Germany, Unfunded	CRO offering early stage drug development services	-	-	40/100